Abstract
Purpose
The use of two solvent-casted film methods to select optimal polymer compositions for amorphous solid dispersions prepared to support preclinical pharmacokinetic and toxicology studies is described.
Methods
Evaporation of solvent from cover slips by using nitrogen flow, and solvent removal from vials by using rotary evaporation were employed. The films prepared on cover slips were evaluated under the microscope to determine crystallinity. The methods were validated by scaling up corresponding SDDs, evaluating SDD’s dissolution, and comparing those results to the dissolution of drug-polymer films. Subsequently, SDD suspensions were prepared and dosed orally to rats to determine pharmacokinetic parameters. This was done by using three compounds from our pipeline and evaluating multiple polymers.
Results
The dissolution of generated films showed good agreement with the dissolution of spray dried dispersions when the films were fully amorphous (Compound A and B). In contrast, there was disagreement between film and SDD dissolution when the films had crystallized (Compound C). The in vivo exposure results indicated that the polymer choice based on the film screening methods would have been accurate for drug-polymer films that were amorphous (Compound A and B). Two additional case studies (Compound D and E) are presented, showing good agreement between in vivo and in vitro results.
Conclusion
This study established the ability of two film casting screening methods to predict the in vitro and in vivo performance of corresponding SDDs, provided that the films are fully amorphous.
Similar content being viewed by others
Abbreviations
- ASD:
-
Amorphous solid dispersion
- CAP:
-
Cellulose acetate phthalate
- FaSSIF:
-
Fasted state simulated intestinal fluid
- HPMC:
-
Hydroxypropyl methylcellulose
- HPMC-AS:
-
Hydroxypropyl methylcellulose acetate succinate
- HPMC-HP:
-
Hydroxypropyl methylcellulose phthalate
- NF:
-
Nitrogen flow
- PBS:
-
Phosphate buffer saline
- PK:
-
Pharmacokinetics
- PVAP:
-
Polyvinyl acetate phthalate
- RE:
-
Rotary evaporation
- SC:
-
Spin Coating
- SDD:
-
Spray dried dispersion
References
Landis MS, Bhattachar S, Yazdanian M, Morrison J. Commentary: why pharmaceutical scientists in early drug discovery are critical for influencing the design and selection of optimal drug candidates. AAPS PharmSciTech. 2018;19(1):1–10.
Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420(1):1–10.
Van den Mooter G. The use of amorphous solid dispersions: a formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today Technol. 2012;9(2):e79–85.
Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. J Pharm Sci. 2012;101(4):1355–77.
Mosquera-Giraldo LI, Borca CH, Meng X, Edgar KJ, Slipchenko LV, Taylor LS. Mechanistic Design of Chemically Diverse Polymers with applications in Oral drug delivery. Biomacromolecules. 2016;17(11):3659–71.
Mosquera-Giraldo LI, Borca CH, Parker AS, Dong Y, Edgar KJ, Beaudoin SP, et al. Crystallization inhibition properties of cellulose esters and ethers for a Group of Chemically Diverse Drugs: experimental and computational insight. Biomacromolecules. 2018;19(12):4593–606.
Poozesh S, Mahdi JS. Are traditional small-scale screening methods reliable to predict pharmaceutical spray drying? Pharm Dev Technol. 2019;24(7):915–25.
Hu Q, Wyttenbach N, Shiraki K, Choi DS. Miniaturized screening tools for polymer and process evaluation. In: Shah N, Sandhu H, Choi DS, Chokshi H, Malick AW, editors. Amorphous solid dispersions: theory and practice. New York: Springer New York; 2014. p. 165–95.
Honick M, Sarpal K, Alayoubi A, Zidan A, Hoag SW, Hollenbeck RG, et al. Utility of films to anticipate effect of drug load and polymer on dissolution performance from tablets of amorphous Itraconazole spray-dried dispersions. AAPS PharmSciTech. 2019;20(8):331.
Wyttenbach N, Janas C, Siam M, Lauer ME, Jacob L, Scheubel E, et al. Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid assessment of solid dispersion systems. Eur J Pharm Biopharm. 2013;84(3):583–98.
Banda A, Manchanda A, Zhang W, Alba GM, Nagapudi K. Comparative assessment of miniaturized screening approaches for selection of polymers for amorphous drug stabilization. J Pharm Sci. 2018;107(3):897–908.
Vandecruys R, Peeters J, Verreck G, Brewster ME. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. Int J Pharm. 2007;342(1):168–75.
Shanbhag A, Rabel S, Nauka E, Casadevall G, Shivanand P, Eichenbaum G, et al. Method for screening of solid dispersion formulations of low-solubility compounds—miniaturization and automation of solvent casting and dissolution testing. Int J Pharm. 2008;351(1):209–18.
Auch C, Harms M, Mäder K. Melt-based screening method with improved predictability regarding polymer selection for amorphous solid dispersions. Eur J Pharm Sci. 2018;124:339–48.
Hu Q, Choi DS, Chokshi H, Shah N, Sandhu H. Highly efficient miniaturized coprecipitation screening (MiCoS) for amorphous solid dispersion formulation development. Int J Pharm. 2013;450(1):53–62.
Newman A. Pharmaceutical amorphous solid dispersions: John Wiley & Sons; 2015.
Ousset A, Chavez P-F, Meeus J, Robin F, Schubert MA, Somville P, et al. Prediction of phase behavior of spray-dried amorphous solid dispersions: assessment of thermodynamic models, standard screening methods and a novel atomization screening device with regard to prediction accuracy. Pharmaceutics. 2018;10(1):29.
Ousset A, Bassand C, Chavez P-F, Meeus J, Robin F, Schubert MA, et al. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development. Pharm Dev Technol. 2019;24(5):560–74.
Duarte Í, Santos JL, Pinto JF, Temtem M. Screening methodologies for the development of spray-dried amorphous solid dispersions. Pharm Res. 2015;32(1):222–37.
Price DJ, Nair A, Kuentz M, Dressman J, Saal C. Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations. Eur J Pharm Sci. 2019;132:142–56.
Han R, Xiong H, Ye Z, Yang Y, Huang T, Jing Q, Lu J, Pan H, Ren F, Ouyang D. Predicting physical stability of solid dispersions by machine learning techniques. Journal of Controlled Release. 2019;311–312:16–25.
Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JAS. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm. 2008;5(6):1003–19.
Van Eerdenbrugh B, Taylor LS. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol Pharm. 2010;7(4):1328–37.
Hancock BC. Predicting the crystallization propensity of drug-like molecules. J Pharm Sci. 2017;106(1):28–30.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
Additional Information can be found in the supplemental material: bioanalysis methods, chromatography methods for in vitro dissolution experiments; pharmacokinetic parameters corresponding to analysis of compound A, B, and C; classification of compound A, B, C and E in the Tm/Tg versus Log P diagram; characterization of polymer films; powder X-ray diffraction results for compound C SDDs; microscopy film pictures for Compound D and E; and description of polymer composition. (DOCX 6830 kb)
Rights and permissions
About this article
Cite this article
Mosquera-Giraldo, L.I., Donoso, M., Stefanski, K. et al. Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration. Pharm Res 38, 901–914 (2021). https://doi.org/10.1007/s11095-021-03040-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-021-03040-w